Medicine and Dentistry
Breast Cancer
18%
Epidermal Growth Factor Receptor 2
100%
Estrogen Receptor
9%
Fluorescence in Situ Hybridization
100%
Gamma Urogastrone
100%
Image Analysis
9%
Lymph Node
9%
Neoplasm
36%
Oncotype DX
100%
Recurrent Disease
9%
Reverse Transcription Polymerase Chain Reaction
100%
Keyphrases
Breast Cancer Patients
8%
Discrepant Cases
25%
Estrogen Receptor-positive
8%
Fluorescence in Situ Hybridization
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Image Analysis
8%
Invasive Breast Cancer
8%
Invasive Tumors
16%
Lymph Node Positive
8%
Microdissection
8%
Oncotype DX
100%
Optimal Testing
8%
Patient Characteristics
8%
Percent Agreement
8%
Positive Lymph Nodes
8%
Protein Drug
8%
Quantitative PCR
100%
Recurrence Score
8%
Relative Proportion
8%
Testing Method
8%
Tissue Block
8%
Tumor
8%
Tumor Characteristics
8%
Neuroscience
Epidermal Growth Factor Receptor 2
100%
Estrogen Receptor
9%
Gamma Urogastrone
100%
In Situ Hybridization
100%
Lymph Node
9%
Reverse Transcription Polymerase Chain Reaction
100%
Agricultural and Biological Sciences
Epidermal Growth Factor Receptor
100%
Estrogen Receptor
9%
Fluorescence in Situ Hybridization
100%
Image Analysis
9%
Lymph Node
9%
Protein Product
9%
Reverse Transcription Polymerase Chain Reaction
100%
Immunology and Microbiology
Fluorescence in Situ Hybridization
100%
Gamma Urogastrone
100%
Lymph Node
9%
Microdissection
9%
Reverse Transcription Polymerase Chain Reaction
100%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Estrogen Receptor
9%
Fluorescence in Situ Hybridization
100%
Microdissection
9%
Reverse Transcription Polymerase Chain Reaction
100%